Novo Nordisk's pricing methods from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of rate gouging, declaring the stark contrast amongst U.S. rates and those in Europe and copyright. Understanding the generation expenses is essential